G01N 33/505
Involving t-cells
Official title: {involving T-cells}
G01N33/505 (Involving t-cells) appears on 1,087 US grants and 2,296 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,087
- Published applications
- 2,296
- Assignees
- 787
- Inventors
- 3,281
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 2 | 0 |
| 1998 | 20 | 0 |
| 1999 | 15 | 0 |
| 2000 | 7 | 0 |
| 2001 | 14 | 4 |
| 2002 | 15 | 32 |
| 2003 | 16 | 477 |
| 2004 | 11 | 84 |
| 2005 | 11 | 71 |
| 2006 | 33 | 66 |
| 2007 | 81 | 56 |
| 2008 | 88 | 47 |
| 2009 | 33 | 63 |
| 2010 | 41 | 61 |
| 2011 | 28 | 56 |
| 2012 | 27 | 71 |
| 2013 | 34 | 49 |
| 2014 | 29 | 47 |
| 2015 | 32 | 62 |
| 2016 | 37 | 89 |
| 2017 | 44 | 81 |
| 2018 | 66 | 96 |
| 2019 | 49 | 101 |
| 2020 | 53 | 122 |
| 2021 | 62 | 130 |
| 2022 | 57 | 124 |
| 2023 | 46 | 100 |
| 2024 | 53 | 84 |
| 2025 | 41 | 81 |
| 2026 | 34 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Method of assessing activity of recombinant antigen receptors11 Aug 2026US 12,703,734 B2Juno Therapeutics, Inc.
- Methods and systems for determining metabolic poise and capacity of living cells11 Aug 2026US 12,704,502 B2Agilent Technologies, Inc.
- Small molecules for dual function positron emission tomography (PET) and cell suicide switches4 Aug 2026US 12,697,403 B2The Trustees of the University of Pennsylvania
- HLA class II-restricted DRB T cell receptors against RAS with G12V mutation16 Jun 2026US 12,655,194 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Ligand discovery and gene delivery via retroviral surface display8 Oct 2026US 2026/0309700 A1Massachusetts Institute of Technology
- Compositions and methods for determining the effects of t cell engager8 Oct 2026US 2026/0309708 A1Arbele Limited
- Label-free methods for assessing cell state in a biological sample24 Sep 2026US 2026/0287575 A1Elephas Biosciences Corporation
Most cited
By later US patents
- Human secreted proteins202US 7,368,531 B2Human Genome Sciences, Inc. · 2008
- Tolerogenic synthetic nanocarriers for inducing regulatory B cells129US 8,652,487 B2Selecta Biosciences, Inc. · 2014
- G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof125US 5,939,320 ANew York University · 1999
- Methods and systems for analysis of chromatin115US 10,725,027 B210x Genomics, Inc. · 2020
- Methods for screening for compounds that modulate pd-1 signaling113US 7,105,328 B2Dana-Farber Cancer Institute, Inc. · 2006